Steris

STE · NYSE · USD

$208.54Change from previous close: −0.38%Absolute change: −$0.80

Close · October 2, 2026

At a glance

Revenue growth
+8.73%
FY to Mar 2026 vs FY to Mar 2025
Net income growth
+27.27%
FY to Mar 2026 vs FY to Mar 2025
Net margin
13.2%
FY to Mar 2025: 11.3%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Total assets10,73610,73710,59110,41110,405—
Current assets2,4462,3952,2862,1062,058—
Cash and equivalents482440424319280—
Receivables1,0131,093991947947—
Inventory712632674659641—
Net property, plant and equipment2,3232,3172,2882,2522,218—
Goodwill4,1894,1954,2324,2154,223—
Other intangible assets1,5641,6201,6921,7491,817—
Current liabilities1,2831,145922889927—
Accounts payable344339285309301—
Long-term debt1,6501,8131,8981,8971,903—
Total debt2,0452,0872,0542,0592,069—
Total liabilities3,5153,5403,4243,3883,435—
Total equity (incl. minority)7,2217,1977,1687,0236,970—
Retained earnings3,1553,0162,8572,7262,597—
Minority interest14.513.613.413.512.9—